Fortis Healthcare Limited carries a market capitalization of 739.90B, placing it among publicly traded companies globally. Its enterprise value stands at 631.72B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 739.90B |
| Enterprise Value | 631.72B |
Fortis Healthcare Limited currently has 754.96M shares outstanding.
| Shares Outstanding | 754.96M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Fortis Healthcare Limited trades at a trailing price-to-earnings ratio of 57.60. The price-to-sales ratio is 6.57, and the price-to-book ratio stands at 79.48.
| PE Ratio | 57.60 |
| PS Ratio | 6.57 |
| PB Ratio | 79.48 |
| P/TBV Ratio | 12.44 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Fortis Healthcare Limited trades at an EV/EBITDA multiple of 38.62 and an EV/FCF ratio of 257.83. The EV/Sales ratio of 6.92 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 38.62 provides insight into valuation relative to core operating earnings.
| EV / Sales | 6.92 |
| EV / EBITDA | 38.62 |
| EV / EBIT | 38.62 |
| EV / FCF | 257.83 |
Fortis Healthcare Limited maintains a current ratio of 0.86, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 34.15, indicating elevated leverage, while an interest coverage ratio of 5.20 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 0.86 |
| Quick Ratio | 0.27 |
| Debt / Equity | 34.15 |
| Debt / EBITDA | 2.12 |
| Interest Coverage | 5.20 |
Fortis Healthcare Limited posts a return on equity of 96.27 and a return on invested capital of 10.11.
| Return on Equity (ROE) | 96.27 |
| Return on Assets (ROA) | 7.03 |
| Return on Invested Capital (ROIC) | 10.11 |
| Return on Capital Employed (ROCE) | 29.28 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 32.24 |
Over the trailing twelve months, Fortis Healthcare Limited has paid 3.02B in income taxes, reflecting an effective tax rate of 22.09.
| Income Tax | 3.02B |
| Effective Tax Rate | 22.09 |
Fortis Healthcare Limited's stock has gained approximately 21.59429% over the past 52 weeks. The 50-day moving average sits at 959.60, while the 200-day moving average is 926.97.
| Beta (5Y) | N/A |
| 52-Week Price Change | 21.59429% |
| 50-Day Moving Average | 959.60 |
| 200-Day Moving Average | 926.97 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Fortis Healthcare Limited generated 91.28B in revenue and converted that into 10.42B in net income, yielding earnings per share of 14.10. EBITDA reached 16.36B, while operating income came in at 16.36B.
| Revenue | 91.28B |
| Gross Profit | 50.89B |
| Operating Income | 16.36B |
| Pretax Income | 13.66B |
| Net Income | 10.42B |
| EBITDA | 16.36B |
| EBIT | 16.36B |
| Earnings Per Share (EPS) | 14.10 |
Fortis Healthcare Limited holds 5.80B in cash and equivalents against 34.73B in total debt, resulting in a net debt position of 24.66B. Total book value stands at 7.55B, with working capital of -2.96B providing operational flexibility.
| Cash & Cash Equivalents | 5.80B |
| Total Debt | 34.73B |
| Net Debt | 24.66B |
| Equity (Book Value) | 7.55B |
| Book Value Per Share | 10.00 |
| Working Capital | -2.96B |
Fortis Healthcare Limited operates with a gross margin of 55.76, reflecting its pricing power and cost economics. The operating margin of 17.92 and net profit margin of 11.41 provide insight into operational efficiency.
| Gross Margin | 55.76 |
| Operating Margin | 17.92 |
| Pretax Margin | 14.96 |
| Profit Margin | 11.41 |
| EBITDA Margin | 17.92 |
Fortis Healthcare Limited posts an Altman Z-Score of 7.54, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.54 |